Kura Oncology created Caspian Therapeutics for diabetes research, which is backed by Eli Lilly, with a meeting scheduled in Milan.
3 reports, 3 independent
Updated Oct 13
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Kura Oncology created Caspian Therapeutics for diabetes research, which is backed by Eli Lilly, with a meeting scheduled in Milan.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Eli Lilly participated in Kura Oncology's financing, and Troy Wilson is the CEO.1 source
Eli Lilly participated in Caspian's financing, and Kura Oncology listed on Nasdaq.1 source
Kura Oncology launches Caspian Therapeutics for diabetes research, receiving backing from Eli Lilly.1 source
Keep exploring
The entities involved
-
Kura Oncology
company in La Jolla, United States
Nothing else this week.
-
Eli Lilly and Company
American pharmaceutical company
-
Milan
Italian commune and capital city of Lombardy